NeOnc Technologies Holdings, Inc. (NTHI)
NASDAQ: NTHI · Real-Time Price · USD
3.270
+0.320 (10.85%)
At close: Oct 23, 2026, 4:00 PM EDT
3.280
+0.010 (0.31%)
After-hours: Oct 23, 2026, 7:30 PM EDT
NeOnc Technologies Holdings Earnings Call Transcripts
Fiscal Year 2026
-
Stockholders elected two Class I directors and approved the equity-plan expansion and FY2026 auditor appointment. The conditional adjournment proposal was also approved, and a quorum was established.
-
NEO100, delivered intranasally, showed a median overall survival of 26.09 months in recurrent IDH1 mutant high-grade glioma, far exceeding the historical six to nine months. The phase II-A trial met its primary endpoint with a PFS6 of 48.9%, and demonstrated durable disease control and favorable tolerability.